Tina Schäfer

Title: The Innovative Contributions of Tina Schäfer

Introduction

Tina Schäfer is a prominent inventor based in Wuerzburg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to her name, her work focuses on innovative solutions for treating cancer cachexia and cancer.

Latest Patents

One of her latest patents involves monoclonal antibodies to growth and differentiation factor 15 (GDF-15). This invention relates to anti-human-GDF-15 antibodies, which include chimeric and humanized antibodies. The patent outlines methods for using these antibodies in the treatment of cancer cachexia and cancer. Additionally, it provides pharmaceutical compositions, kits, methods, and cell lines capable of producing these monoclonal antibodies.

Career Highlights

Tina has worked at the Julius-Maximilians-Universität Würzburg, where she has contributed to various research projects. Her work has been instrumental in advancing the understanding of GDF-15 and its implications in cancer treatment.

Collaborations

Throughout her career, Tina has collaborated with notable colleagues such as Jörg Wischhusen and Markus Junker. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Tina Schäfer's innovative work in the field of monoclonal antibodies showcases her dedication to advancing cancer treatment. Her contributions are paving the way for new therapeutic options and improving patient outcomes.